Results 121 to 130 of about 55,691 (247)

Atorvastatin preserved endothelial barrier integrity.

open access: yes, 2013
(A) atorvastatin enhances endothelial cell junctional integrity. Changes in transendothelial electrical resistance (TER) were recorded by ECIS under varying conditions. Thrombin treatment caused a dramatic decrease in resistance, reaching a maximum at 30
Keqiang Zuo (389241)   +3 more
core   +1 more source

Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis

open access: yes, 2019
Mohammadreza Sobhan,1 Ghazal Gholampoor,2 Farzin Firozian,3,4 Younes Mohammadi,5 Maryam Mehrpooya21Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran; 2Department of Clinical ...
Firozian F   +4 more
core  

Novel approach to reduce postsurgical adhesions to a minimum: Administration of losartan plus atorvastatin intraperitoneally

open access: yes, 2013
Background\ud \ud Intraperitoneal adhesions are the most important cause of intestinal obstruction, pelvic pain, and female infertility.\ud \ud Materials and methods\ud \ud Losartan (1, 5, and 10 mg/kg), atorvastatin (1, 20, and 30 mg/kg), losartan (10 ...
Dinarvand, Peyman   +7 more
core   +1 more source

[Atorvastatin in primary prevention]. [Birincil korunmada atorvastatin.]

open access: yes, 2009
Statins are one of the most widely used drugs in medical treatment and have been shown to prevent cardiovascular disease or reduce risk in a large number of studies. Although there is a general class effect, there are differences with regard to structure
Kültürsay H.
core  

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3246-3256, September 2026.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind   +7 more
wiley   +1 more source

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction

open access: yes, 2017
Mara Gavazzoni,1 Elio Gorga,1 Giuseppe Derosa,2–5 Pamela Maffioli,2,4 Marco Metra,1 Riccardo Raddino1 1Cardiology Department, University of Brescia, Spedali Civili di Brescia, Brescia, 2Centre of Diabetes and Metabolic Diseases, Department of ...
Raddino R   +5 more
core  

Effect of atorvastatin on the xenobioitic detoxification of blue mussels, Mytilus edulis

open access: yes, 2019
Increasing concentration of biologically active pharmaceutical compounds can affect marine organisms. The bioavailability and environmental stability of these compounds make them potential threat to these organisms, specially the sessile organisms.
Sabrina Glufke (7884569)   +19 more
core   +1 more source

A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3257-3264, September 2026.
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are widely used in patients with cystic fibrosis and significantly improve respiratory function and quality of life. However, their effectiveness may be limited by liver damage, which sometimes leads to treatment discontinuation, and the mechanisms underlying this remain poorly ...
Clara Laffitte Redondo   +12 more
wiley   +1 more source

Correlation of atorvastatin with subjective memory deficits: a study from the NHANES and FAERS databases

open access: yesFrontiers in Neurology
BackgroundPost-marketing regulatory data suggest a potential association between atorvastatin use and memory protection; however, findings from observational studies have been inconsistent and remain a subject of controversy.ObjectiveThis study aims to ...
Hao Zhang, Hua Huang, Panli Zhao
doaj   +1 more source

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

open access: yes, 2014
Elizabeth Marrett,1 Changgeng Zhao,1 Ning Jackie Zhang,2 Qiaoyi Zhang,1 Dena R Ramey,1 Joanne E Tomassini,1 Andrew M Tershakovec,1 David R Neff11Merck & Co, Inc., Whitehouse Station, NJ, USA; 2College of Health and Public Affairs, University of ...
Tomassini JE   +7 more
core  

Home - About - Disclaimer - Privacy